In order to capture potential subtype heterogeneity, 4 different ALL subtypes were selected including two TCF3::HLF positive B-ALLs, two TCF3::PBX1 B-ALLs, one cortical T-ALL and one pre-T-ALL. This evidence concerns the gene TCF3 and acute lymphoblastic leukemia.